In addition, our current data offers compelling evidence to suggest that, albeit not activated yet, human keloid- and HS-derived fibroblasts, or at least a subpopulation of these cells, can replicate the targeted apoptosis of BJ- and NHDF-converted myofibroblasts in response to IL1β and FMOD. The gene discussed is IL1B; the disease is keloid.